Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Olfactory transduction | R-HSA-9751605 | map04740 | trazodone | 5533 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | trazodone | 5533 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | zidovudine | 5202 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | zidovudine | 5202 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | zidovudine | 5202 | drug-path |
Complement and coagulation cascades | R-HSA-114591 | map04610 | zidovudine | 5202 | drug-path |
Glioma | Q9NZM4 | map05214 | zidovudine | 5202 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | zidovudine | 5202 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | zidovudine | 5202 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | zidovudine | 5202 | drug-path |
Shigellosis | 0 | map05131 | zidovudine | 5202 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | zidovudine | 5202 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | zidovudine | 5202 | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | zidovudine | 5202 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | zidovudine | 5202 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | zidovudine | 5202 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | butirosin | 72393 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | butirosin | 72393 | drug-path |
Shigellosis | 0 | map05131 | butirosin | 72393 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | butirosin | 72393 | drug-path |